- Home
- XTNT vs ABP Comparison
XTNT vs ABP Comparison
Compare XTNT & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ABP
- Stock Information
- Founded
- XTNT N/A
- ABP 2004
- Country
- XTNT United States
- ABP United States
- Employees
- XTNT N/A
- ABP N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- ABP Health Care
- Exchange
- XTNT Nasdaq
- ABP Nasdaq
- Market Cap
- XTNT 83.2M
- ABP 76.2M
- IPO Year
- XTNT N/A
- ABP N/A
- Fundamental
- Price
- XTNT $0.59
- ABP $0.84
- Analyst Decision
- XTNT Strong Buy
- ABP
- Analyst Count
- XTNT 1
- ABP 0
- Target Price
- XTNT $3.00
- ABP N/A
- AVG Volume (30 Days)
- XTNT 50.3K
- ABP 39.1K
- Earning Date
- XTNT 03-31-2025
- ABP 03-07-2025
- Dividend Yield
- XTNT N/A
- ABP N/A
- EPS Growth
- XTNT N/A
- ABP N/A
- EPS
- XTNT N/A
- ABP N/A
- Revenue
- XTNT $113,862,000.00
- ABP $230,000.00
- Revenue This Year
- XTNT $31.27
- ABP N/A
- Revenue Next Year
- XTNT $13.07
- ABP N/A
- P/E Ratio
- XTNT N/A
- ABP N/A
- Revenue Growth
- XTNT 45.11
- ABP N/A
- 52 Week Low
- XTNT $0.33
- ABP $0.80
- 52 Week High
- XTNT $1.30
- ABP $13.00
- Technical
- Relative Strength Index (RSI)
- XTNT 52.36
- ABP N/A
- Support Level
- XTNT $0.55
- ABP N/A
- Resistance Level
- XTNT $0.62
- ABP N/A
- Average True Range (ATR)
- XTNT 0.05
- ABP 0.00
- MACD
- XTNT -0.01
- ABP 0.00
- Stochastic Oscillator
- XTNT 41.76
- ABP 0.00
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.